<DOC>
	<DOC>NCT01203709</DOC>
	<brief_summary>A trial of combination of two drugs for the treatment of refractory lupus nephritis.</brief_summary>
	<brief_title>Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis</brief_title>
	<detailed_description>Low-dose combination of mycophenolate mofetil and tacrolimus for refractory lupus nephritis: a 12-month prospective study</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>1. Active nephritis documented by renal biopsy within 24 months of entry; 2. Failure to respond to 2 or more immunosuppressive regimens which consisted of highdose prednisolone combined with other noncorticosteroid immunosuppressive agents together with ACE inhibitors plus or minus angiotensin receptor blockers (ARB) for at least 4 months for each regimen at the maximally tolerated drug dosages; 3. Serum creatinine (Scr) less than 200umol/L. 1. Previous intolerance to either MMF/Tac; 2. Scr &gt;200umol/L; 3. Informed consent unavailable.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>lupus</keyword>
	<keyword>nephritis</keyword>
	<keyword>glomerulonephritis</keyword>
	<keyword>nephropathy</keyword>
	<keyword>refractory</keyword>
</DOC>